MARIA MARRERO: Open Payments
NPI 1396122784 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,941 in 122 payments from 32 companies in 2025. Trend: 2023 $3,449 · 2024 $4,958 · 2025 $2,941
Food & beverage: $2,858Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $365 |
| AstraZeneca Pharmaceuticals LP | 13 | $307 |
| E.R. Squibb & Sons, L.L.C. | 10 | $207 |
| Celgene Corporation | 6 | $152 |
| Merck Sharp & Dohme LLC | 7 | $151 |
| Novartis Pharmaceuticals Corporation | 7 | $147 |
| Karyopharm Therapeutics Inc. | 3 | $139 |
| Eisai Inc. | 7 | $132 |
| ARRAY BIOPHARMA INC | 5 | $122 |
| Genentech USA, Inc. | 5 | $115 |
Products named: OPDIVO, ELAHERE, KEYTRUDA, XPOVIO, Lenvima, REBLOZYL, AUGMENT INJECTABLE, CALQUENCE.
Industry payments across IN — which companies pay providers there.
